Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rexona is a global leader in the consumer health and personal care sector, specifically within the antiperspirant and deodorant market. Owned by Unilever, the brand is built on a foundation of dermatological research and sweat physiology, leading to the development of high-performance moisture and odor control products. Its proprietary MotionSense technology utilizes friction-activated microcapsules to provide long-lasting protection tailored to physical activity. Rexona's portfolio includes clinical-grade formulations that address conditions such as hyperhidrosis, positioning the brand at the intersection of cosmetic hygiene and therapeutic skin care. The brand operates globally under various trademarks, including Degree in North America and Sure in the United Kingdom, maintaining a dominant share of the hygiene market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rexona.